NCT02299388View on ClinicalTrials.gov

To Evaluate the Effect of Liraglutide on Ambulatory Blood Pressure-A Pilot Study

PHASE4CompletedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

November 30, 2016

Study Completion Date

December 31, 2016

Conditions
Diabetes Mellitus, Non-Insulin-DependentHypertensive Disease
Interventions
DRUG

Liraglutide or Placebo

All subjects will be advised a low sodium diet. Eligible patients will have ABPM measurements and laboratory blood collection at baseline (prior to initiation of Liraglutide or Placebo), at 4 and 8 weeks of therapy. Patients will return 24 hours following ABPM placement for device and data retrieval.

Trial Locations (1)

70112

Tulane University Health Science Center, Tidewater building and Tulane Hospital and Clinics, New Orleans

Sponsors

Collaborators (1)

Novo Nordisk A/S
All Listed Sponsors
collaborator

Novo Nordisk A/S

INDUSTRY

lead

Tulane University School of Medicine

OTHER